FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
The Food and Drug Administration on Thursday fully approved the Alzheimer’s treatment Leqembi, a pivotal decision that will expand access to the expensive drug for… Read More »FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage